Sara García Barcenilla: High-Quality Care for People with Hemophilia and Congenital Bleeding Disorders
Sara García Barcenilla, Nurse in the Thrombosis and Hemostasis Unit, La Paz-IdiPAZ University Hospital, shared an insightful post on LinkedIn:
”I am very very excited about the recent publication of our first approach to defining the competencies and optimal curriculum for hemophilia nurses in Spain!
We have worked with several nurses across the country and have reached consensus on the knowledge and skills nurses need at basic, advanced, and expert levels, our role in treatment management, monitoring patient-reported outcomes, and the importance of education and communication with patients, families, and colleagues.
This proposed three-tiered stratification could help define programs, accreditations, and policies, promoting consistent, high-quality care for people with hemophilia and congenital bleeding disorders.
Many thanks to the participating nurses and to the methodological support from Roche and Evidence.
This is my first article as lead author, and their experience and guidance have been key to my understanding of the process of preparing and disseminating our results.”
Read the full open-access article here.
Article: Identifying Professional Responsibilities and Designing the Optimal Curriculum for Haemophilia Nurses in Spain: A Round Table Discussion
Authors: Sara García-Barcenilla, Montserrat Rambla Pérez, Noelia Pérez, Alfonso Castro Blanco, Anna Diaz, Carmen Fernandez Sarmiento, Eva Álvarez Martínez, María Dolores de Dios, María del Carmen García Martínez, María Teresa Torres, Mercè Triquell Garrell, Nuria Caballero Mencía, María Antonia Fernández
Stay updated on all science in the field of Hemophilia and Bleeding Disorders with Hemostasis Today.
-
Aug 10, 2025, 02:59What's Hot in Clots – August 2025: Explore AF, PFO, STROKE, Antithrombotics and Cancer in One
-
Aug 8, 2025, 18:06Catch Up on Anticoagulation Forum Newsletter: Explore The Upcoming
-
Aug 8, 2025, 15:28Claudio Laudani: New Insights on P2Y12 Monotherapy in Antiplatelet Therapy
-
Aug 8, 2025, 11:59Wolfgang Miesbach on Frailty in Hemophilia: New Data Shows 3x Higher Risk
-
Aug 8, 2025, 06:26Francisco López Romero-Salazar Shares A Closer Look at ROTEM and Thrombin Generation Assays
-
Aug 10, 2025, 09:09Biomarkers of RUNX1-RT Patients: Inherited Thrombocytipenia and Malignancy Risk
-
Aug 10, 2025, 08:35Emmanuel J Favaloro Shares The Tatest Issue of Seminars in Thrombosis and Hemostasis
-
Aug 10, 2025, 06:33CRH: Hereditary Combined Deficiency of the Vitamin K-Dependent Coagulation Factors
-
Aug 10, 2025, 06:01Karl Desch Shares Insights On a Recent Study on GWAS by Thibord et al
-
Aug 10, 2025, 04:39Sara García Barcenilla: High-Quality Care for People with Hemophilia and Congenital Bleeding Disorders
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
-
Aug 8, 2025, 18:33Hemophilia Alliance during Tennessee Hemophilia and Bleeding Disorders Foundation Annual Meeting 2025
-
Aug 7, 2025, 14:49JAMA+AI Conversations: David Rhew's Journey from Clinical Practice to Technology Leadership
-
Aug 6, 2025, 16:47My Clot Story: Birth Control and A Life-threatening Pulmonary Embolism
-
Aug 5, 2025, 17:59Heghine Khachatryan: Honored to Be Part of The WFH Regional Workshop 2025